Furthermore, in our cohort, the prevalence of BRAF V600E mutations appeared numerically higher in the TERT-mutated group (89.5 vs 77.1%); however, this difference did not reach statistical significance ( P = 0.055).
← all excerpts
Integrating TERT promoter mutations into risk stratification of papillary thyroid cancer.
1
0.0550
0.0550